Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
SEDE NON SPECIFICATA | NEW YORK, Dec. 07, 2023 (GLOBE NEWSWIRE) -- VAST Data, la società di piattaforme di dati per l’IA, ha annunciato oggi di essersi assicurata un finanziamento di 118 milioni di...
-
Newark, Dec. 04, 2023 (GLOBE NEWSWIRE) -- The Brainy Insights estimates that the USD 112.6 billion western wear market will reach USD 185.1 billion by 2032. The phrase "western wear" refers...
-
VANCOUVER, British Columbia, Nov. 20, 2023 (GLOBE NEWSWIRE) -- ValOre Metals Corp. (“ValOre”; TSX‐V: VO; OTCQB: KVLQF; Frankfurt: KEQ0, “the Company”) today initiated a broad and comprehensive...
-
Verona Pharma plc announces its President and CEO, David Zaccardelli, has won ‘Executive of the Year 2023' at the SCRIP awards.
-
TORONTO, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the...
-
NEW YORK, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Il Dave Cantin Group (“DCG” o “la Società”), consulente leader per i gruppi automobilistici della distribuzione e i loro proprietari, ha annunciato oggi...
-
€106,1 millions de ventes de produits, soit une hausse de 42,6% par rapport aux neuf premiers mois de 2022 Les ventes d’IXIARO® et de DUKORAL® ont bénéficié de la reprise continue du marché des...
-
Product sales of €106.1 million, an increase of 42.6% compared to the first nine months of 2022 IXIARO® and DUKORAL® sales benefited from a continued recovery of the travel industryTotal revenues of...
-
LONDON and RALEIGH, N.C., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”), announces that senior management will present a company overview at...
-
US FDA accepted NDA filing for ensifentrine for maintenance treatment of COPD PDUFA Target Action Date of June 26, 2024 Commercial launch preparations supported by strong balance sheet Conference...